Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Authors
Nancy Lin,
Virginia BorgesCarey Anders,
Rashmi Murthy,
Elisavet Paplomata,
Erika Hamilton,
Sara Hurvitz,
Sherene Loi,
Alicia Okines,
Vandana Abramson,
Philippe Bédard,
Mafalda Oliveira,
Volkmar Mueller,
Amelia Zelnak,
Michael DiGiovanna,
Thomas Bachelot,
A. Chien,
Ruth O’Regan,
Andrew Wardley,
Alison Conlin,
David Cameron,
Lisa Carey,
Giuseppe Curigliano,
Karen Gelmon,
Sibylle Loibl,
JoAl Mayor,
Suzanne McGoldrick,
Xuebei An,
Eric Winer,
Philippe Bedard +28 authors
,
Volkmar Müller Tip Tip